Revisão Acesso aberto Revisado por pares

Thoracic oncology HERMES: European curriculum recommendations for training in thoracic oncology

2016; European Respiratory Society; Volume: 12; Issue: 3 Linguagem: Inglês

10.1183/20734735.009116

ISSN

2073-4735

Autores

Fernando Gamarra, Julie-Lyn Noël, Alessandro Brunelli, Anne‐Marie C. Dingemans, Enriqueta Felip, Mina Gaga, Bogdan Grigoriu, Georgia Hardavella, Rudolf M. Huber, Sam M. Janes, Gilbert Massard, Paul Martin Putora, Jean‐Paul Sculier, Philipp A. Schnabel, Sara Ramella, Dirk Van Raemdonck, Anne‐Pascale Meert,

Tópico(s)

Advances in Oncology and Radiotherapy

Resumo

The HERMES (Harmonising Education in Respiratory Medicine for European Specialists) project is funded by the European Respiratory Society (ERS) and has the declared aims of harmonising education in thoracic medicine, recognising diplomas and certificates of qualification, and improving free access and mobility for medical specialists across the European Union (EU). This takes into account Directive 2013/55/EU of the European Parliament and of the Council [1] on the recognition of professional qualifications, one of the pillars of EU legislation. Moreover, it conforms to the fact that there is a shortage of medical/surgical specialists in several European countries, which means that more physicians of other European and non-European countries will be needed to sustain the functioning and development of health services in future years and decades [2]. HERMES is working towards the development of harmonised and structured programmes for education across respiratory specialties to ensure that the best care is delivered for those suffering from respiratory diseases. Thoracic oncology HERMES: European curriculum recommendations for training in thoracic oncology The authors affiliations are as follows. F. Gamarra: Division of Respiratory Medicine, Klinikum Straubing, Straubing, Germany. J-L. Noël: European Respiratory Society, Lausanne, Switzerland. A. Brunelli: Dept of Thoracic Surgery, St James's University Hospital, Leeds, UK. A.-M.C. Dingemans: Dept of Pulmonology, Maastricht University Medical Centre, Maastricht, Netherlands. E. Felip: Hospital Universitari Vall d'Hebron, Barcelona, Spain. M. Gaga: 7th Respiratory Medicine Dept, Athens Chest Hospital, Athens, Greece. B.D. Grigoriu: University of Medicine and Pharmacy, Regional Institute of Oncology, Iasi, Romania. G. Hardavella: Dept of Respiratory Medicine, King's College Hospital, London, UK, and University College London, Lungs for Living Research Centre, London, UK. R.M. Huber: Division of Respiratory Medicine and Thoracic Oncology, Thoracic Oncology Centre Munich, University of Munich, Munich, Germany. S. Janes: Centre for Respiratory Research, University College London, London, UK. G. Massard: Dept of Thoracic Surgery, University of Strasbourg, Strasbourg, France. P.M. Putora: Dept of Radio-oncology, Kantonsspital St. Gallen, St. Gallen, Switzerland. J-P. Sculier: Intensive Care and Thoracic Oncology, Institut Jules Bordet, Brussels Belgium. P.A. Schnabel: Institut für Allgemeine und Spzielle Pathologie, Saarland University, Homburg/Saar, Germany. S. Ramella: Dept of Radiation Oncology, Campus Bio-Medico University, Rome, Italy. D. Van Raemdonck: Dept of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium. A-P. Meert: Dept of Intensive Care and Thoracic Oncology, Institut Jules Bordet, Brussels, Belgium. We would like to thank the ERS Leadership, Gernot Rohde (Education Council Chair) and Ernst Eber (HERMES Director), as well as the medical education specialists Erik Driessen and Griet Peeraer. We would also like to thank Sharon Mitchell and Alexandra Niculescu (European Respiratory Society), the ERS Thoracic Oncology Assembly, Dirk de Ruysscher and Jesper Grau Eriksen (European Society for Radiotherapy and Oncology), and Rolf Stahel Rainer Wiewrodt (European Society for Medical Oncology). We would also like to thank the following national respondents: M. Nanushi (Albania), S. Taright (Algeria), H. Marshall (Australia), K. Kirchbacher (Austria), O. Burghuber (Austria), K.N. Uglyanitsa (Belarus), L. Bosquee (Belgium), M. Bakir (Bosnia/Herzegovina), M. Zamboni (Brazil), A. Kousoulova (Bulgaria), I. Novakov (Bulgaria), N. Bouchard (Canada), V. Ivcevic (Croatia), J. Skrikova (Czech Republic), J. Skrickova (Czech Republic), T.R. Rasmussen (Denmark), T. Laisaar (Estonia), J. Jaal (Estonia), R. Makitaro (Finland), M. Wislez (France), F. Barlesi (France), T. Blum (Germany), E. Stoelben (Germany), K. Gourgouliannis (Greece), J. Moldvay (Hungary), S. Jonsson (Iceland), A. Mohan (India), R. Morgan (Ireland), M. Kennedy (Ireland), Y. Schwarz (Israel), S. Elia (Italy), M. Beishembaev (Kyrgyzstan), A. Krams (Latvia), E. Danila (Lithuania), M. Schlesser (Luxembourg), S. Brincat (Malta), K. Skaug (Norway), J. Domagala-Kulawik (Poland), R. Sotto Mayor (Portugal), D. Jovanovic (Republic of Serbia), C. Paleru (Romania), D. Jovanovic (Serbia), P. Bezinec (Slovakia), E. Kavcova (Slovakia), N. Triller (Slovenia), I. Alfageme (Spain), G. Hillerdal (Sweden), L. Wannesson (Switzerland), S. Burgers (The Netherlands), H.J.M. Groen (The Netherlands), A. Erbaycu (Turkey), N. Lukavetskyy (Ukraine), P. Beckett (UK), M. Peake (UK), L. Kamman (USA) and O. Ioachimescu (USA).

Referência(s)